vTv Therapeutics
Price & Volume
Stats
See more52W Range | $8.10-$30.99 |
Market Cap | $45.8M |
Shares Short | 22,468 |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$9.9M |
Diluted EPS | -$4.37 |
News
See moreYahoo Finance • last year
vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
Yahoo Finance • last year
vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
Yahoo Finance • last year
vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
Yahoo Finance • last year
vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 Million
About
CEO | Mr. Paul J. Sekhri M.Sc. |
CFO | Mr. Steven Tuch M.B.A. |
Address | 3980 Premier Drive, High Point, NC, United States, 27265 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
